Serum theophylline levels with oral sustained release theophylline after transfer from intravenous aminophylline in patients with chronic lung disease.
作者信息
Silins R A, Butcher M A, Marlin G E
出版信息
Br J Clin Pharmacol. 1984 Oct;18(4):645-7. doi: 10.1111/j.1365-2125.1984.tb02521.x.
Abstract
摘要
相似文献
1
Serum theophylline levels with oral sustained release theophylline after transfer from intravenous aminophylline in patients with chronic lung disease.慢性肺病患者从静脉注射氨茶碱转换为口服缓释茶碱后的血清茶碱水平。
Br J Clin Pharmacol. 1984 Oct;18(4):645-7. doi: 10.1111/j.1365-2125.1984.tb02521.x.
2
Comparison of standard- and sustained-release theophylline tablets in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者中标准释放型和缓释型茶碱片的比较。
Am J Hosp Pharm. 1979 May;36(5):613-7.
3
4
5
[Possibilities for optimizing therapy with theophylline preparations. I. On the pharmacokinetics of theophylline preparations].[优化茶碱制剂治疗的可能性。I. 关于茶碱制剂的药代动力学]
Z Erkr Atmungsorgane. 1984;162(1):3-10.
6
Sustained release oral aminophylline in patients with airflow obstruction.气流阻塞患者口服缓释氨茶碱
Thorax. 1981 Apr;36(4):303-7. doi: 10.1136/thx.36.4.303.
7
Comparison of two sustained-release theophylline preparations in adult patients with obstructive airways disease.两种缓释型茶碱制剂在成年阻塞性气道疾病患者中的比较。
J Clin Pharmacol. 1985 Sep;25(6):444-7. doi: 10.1002/j.1552-4604.1985.tb02874.x.
8
Plasma theophylline concentrations in patients with chronic obstructive airways disease after administration of a new sustained release theophylline formulation.慢性阻塞性气道疾病患者服用一种新的茶碱缓释制剂后的血浆茶碱浓度。
Br J Clin Pharmacol. 1982 Apr;13(4):569-71. doi: 10.1111/j.1365-2125.1982.tb01423.x.
9
The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy.从静脉给药转换为口服治疗后口服缓释茶碱的给药设计。
Int J Clin Pharmacol Ther. 1994 Nov;32(11):625-31.
10
[Treatment of chronic obstructive respiratory disease with a new purified theophylline preparation in delayed-action form].[用新型缓释型纯化茶碱制剂治疗慢性阻塞性呼吸道疾病]
Wien Med Wochenschr. 1984 Apr 15;134(7):163-9.
引用本文的文献
1
Oral methyl-xanthines for bronchiectasis.用于支气管扩张症的口服甲基黄嘌呤类药物。
Cochrane Database Syst Rev. 2001;2000(1):CD002734. doi: 10.1002/14651858.CD002734.
2
The effect of respiratory disorders on clinical pharmacokinetic variables.呼吸系统疾病对临床药代动力学变量的影响。
Clin Pharmacokinet. 1990 Dec;19(6):462-90. doi: 10.2165/00003088-199019060-00004.
本文引用的文献
1
Theophylline. A "state of the art" review.茶碱。一篇“前沿技术”综述。
Pharmacotherapy. 1983 Jan-Feb;3(1):2-44. doi: 10.1002/j.1875-9114.1983.tb04531.x.
2
Theophylline disposition in acutely ill hospitalized patients. The effect of smoking, heart failure, severe airway obstruction, and pneumonia.急性病住院患者的茶碱处置。吸烟、心力衰竭、严重气道阻塞及肺炎的影响。
Am Rev Respir Dis. 1978 Aug;118(2):229-38. doi: 10.1164/arrd.1978.118.2.229.
Zotero 插件